Polydeoxyribonucleotide (PDRN), a bioactive molecule long celebrated for its skin-regenerative properties, is undergoing a transformative evolution in the skincare industry. Recent breakthroughs in sourcing, delivery technology and clinical application are shattering traditional limitations, making this powerful ingredient more sustainable, accessible and effective than ever before—marking a new era for regenerative skincare.
Historically, PDRN was primarily extracted from animal sources such as salmon or trout DNA, posing challenges in sustainability, scalability and compatibility for vegan consumers. A pivotal breakthrough comes from Amorepacific’s research team, which has developed “Blue PDRN™”—a microalgal-derived alternative extracted from Chlorella protothecoides. Published in the Archives of Dermatological Research, the study confirms Blue PDRN™ matches the wound-healing and regenerative efficacy of salmon-derived PDRN, while boasting a molecular size 1/20th smaller for enhanced skin penetration and a fully sustainable, animal-free production process.
Clinical research has further unlocked PDRN’s anti-aging potential, particularly for delicate areas like the periocular region. A 28-day randomized, double-blind clinical trial published in the Journal of Cosmetics, Dermatological Sciences and Applications found that PDRN-containing eye cream significantly improved skin elasticity, reduced under-eye bag volume by 18.42% and increased dermal density by 8.67% by modulating multiple cellular pathways—activating collagen production, restoring protein balance and suppressing inflammation. Meanwhile, Innisfree’s vegan Green Tea PDRN™, derived from Jeju green tea post-biotics, has shown 100% of users experienced firmer skin after four weeks of use, catering to eco-conscious consumers without compromising efficacy.
“PDRN’s evolution is reshaping regenerative skincare—from niche medical treatments to mainstream essentials,” said Byung-fhy Suh, CTO of Amorepacific.
Complementing sustainable sourcing, delivery technology has emerged as another key innovation. Traditional topical PDRN products often struggle to penetrate the skin’s barrier, with large molecules breaking down before reaching the dermis. Brands like Venn and Rejuveon have addressed this with cutting-edge solutions: Venn’s nano-encapsulation technology protects full-chain PDRN, delivering it deep into the skin without needles, while Rejuveon’s exosome-based delivery system combines medical-grade PDRN with tiny vesicles to replicate clinic-level results in at-home products. These advancements eliminate the need for invasive microneedling or injections, making PDRN’s benefits accessible to daily skincare routines.
“Our microalgal-derived PDRN, paired with advanced delivery systems, addresses the industry’s biggest pain points: sustainability, accessibility and visible results.”
As demand for science-driven, gentle skincare grows, these breakthroughs position PDRN as a cornerstone ingredient. With sustainable sourcing, needle-free delivery and proven clinical benefits across aging, damage repair and hydration, PDRN is no longer just a luxury—it’s a versatile solution for modern skincare needs. Industry experts predict continued innovation in 2026, with more brands integrating next-generation PDRN formulations to redefine what’s possible for skin regeneration.
Contact Information:
XI'AN BIOF BIO-TECHNOLOGY CO.,LTD
Email: jodie@xabiof.com
Tel/WhatsApp: +86-13629159562
Website: https://www.biofingredients.com
Post time: Feb-03-2026
